Anti‐VEGF vs steroids
Central retinal thickness μm (CRT) change at 1 year The aim of treatment is to reduce central retinal thickness so thinner is better. · people with BRVO
1 finding from 1 review
- Anti‐vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion 2020 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 343 participantsModerate